Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Bullboard (TSXV:TLT)

View:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by Lesalpes29on Nov 15, 2024 7:20am

RE:RE:New Press Release - Theralase(R) Closes Non-Brokered Private Placement

Seems to be enough money until we get BTD in december! GL
37
Discussion
Post by blackjack0on Nov 15, 2024 7:19am

PP news !

I feel this PP closing at 30 cents plus the 45 cent warrants is extremely positive. Finally a pp at or above market close.
50
Comment by Oilminerdeluxeon Nov 15, 2024 7:17am

RE:New Press Release - Theralase(R) Closes Non-Brokered Private Placement

So, let's see what next week brings. Maybe nothing. Maybe nice things.
31
Discussion
Comment by Alamir1111on Nov 14, 2024 11:35pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:That flag formation is still looking good----

https://search.app?link=https%3A%2F%2Fglobalnews.ca%2Fnews%2F10870225%2Ftrump-rfk-jr-health-human-services-nominee%2F&utm_campaign=aga&utm_source=agsadl2%2Csh%2Fx%2Fgs%2Fm2%2F4
52
Discussion
Comment by Alamir1111on Nov 14, 2024 7:53pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:That flag formation is still looking good----

Do you pay capital gains on TFSA? "); display: inline-block; height: 24px; width: 24px; transform-origin: center center; transform: scale3d(1, -1, 1);">      ...more  
79
Discussion
Comment by Alamir1111on Nov 14, 2024 7:41pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:That flag formation is still looking good----

According to Td bank Do I have to pay income tax on my TFSA withdrawals in Canada? No, you dont have to pay income tax on the amounts you withdraw. As TFSA withdrawals dont count ...more  
100
Discussion
Comment by Alamir1111on Nov 14, 2024 7:32pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:That flag formation is still looking good----

I kind of like  the 20 /40/40 set up 20% margin account to play around 40 % Rrsp which is pretty straight forward which tax bracket you're in Tfsa  is a grey area  investing ok ...more  
73
Discussion
Comment by thadeushon Nov 14, 2024 7:03pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:That flag formation is still looking good----

I agree and I've read as much on forums where people were hit hard with unexpected tax consequences. The problem is that it is completely arbitrary - there are no clear rules for trading within a ...more  
130
Discussion
Comment by CancerSlayeron Nov 14, 2024 6:57pm

RE:RE:RE:RE:RE:RE:RE:RE:That flag formation is still looking good----

Americans can certainly count their lucky stars... 0% Rate: Single filers: Up to $48,350 Married filing jointly: Up to $96,700 Head of household: Up to $64,750 15% Rate: Single filers: $48 ...more  
118
Discussion
Comment by skier59on Nov 14, 2024 5:04pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:That flag formation is still looking good----

That's nonsense. You can trade in your TFSA. What you can't do is day trade in your TFSA, or do some strange type trading between accounts. It is the day traders they are looking for, not ...more  
120
Discussion
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT

Visit Facebook Visit X Visit Linked In Visit Instagram Visit Youtube



INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250